Literature DB >> 27160261

[Severe pneumonia in the intensive care unit].

T Welte1.   

Abstract

Pneumonia has a high morbidity and mortality and is responsible for significant healthcare costs. In Germany, two evidence-based recommendations for the treatment of pneumonia are available: the S3 Guideline for Prevention, Diagnosis and Treatment of Adult Patients with Community-acquired Pneumonia and the S3 Guideline on Epidemiology, Diagnosis and Treatment of Nosocomial Pneumonia. On this basis, individualised patient management as shown in this article may be established.

Entities:  

Keywords:  Antibiotics; Community acquired pneumonia; Nosocomial pneumonia; Organ failure; Risk assessment

Mesh：

Substances：

Year:  2016        PMID： 27160261     DOI： 10.1007/s00063-016-0165-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN： 2193-6218            Impact factor:   0.840


  38 in total

Review 1.  [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management].

Authors:  U Kreppein; P Litterst; M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-02-22       Impact factor: 0.840

2.  Quality indicators to measure appropriate antibiotic use in hospitalized adults.

Authors:  Caroline M A van den Bosch; Suzanne E Geerlings; Stephanie Natsch; Jan M Prins; Marlies E J L Hulscher
Journal:  Clin Infect Dis       Date:  2014-09-28       Impact factor: 9.079

Review 3.  Reviving old antibiotics.

Authors:  Ursula Theuretzbacher; Françoise Van Bambeke; Rafael Cantón; Christian G Giske; Johan W Mouton; Roger L Nation; Mical Paul; John D Turnidge; Gunnar Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2015-06-10       Impact factor: 5.790

4.  [Ventilation therapy - a success story].

Authors:  T Welte
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-04       Impact factor: 0.840

5.  [Management of Adult Community-acquired Pneumonia and Prevention - Update 2016].

Authors:  S Ewig; G Höffken; W V Kern; G Rohde; H Flick; R Krause; S Ott; T Bauer; K Dalhoff; S Gatermann; M Kolditz; S Krüger; J Lorenz; M Pletz; A de Roux; B Schaaf; T Schaberg; H Schütte; T Welte
Journal:  Pneumologie       Date:  2016-02-29

6.  Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Authors:  Richard G Wunderink; Michael S Niederman; Marin H Kollef; Andrew F Shorr; Mark J Kunkel; Alice Baruch; William T McGee; Arlene Reisman; Jean Chastre
Journal:  Clin Infect Dis       Date:  2012-01-12       Impact factor: 9.079

7.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.

Authors:  Jean-Pierre Frat; Arnaud W Thille; Alain Mercat; Christophe Girault; Stéphanie Ragot; Sébastien Perbet; Gwénael Prat; Thierry Boulain; Elise Morawiec; Alice Cottereau; Jérôme Devaquet; Saad Nseir; Keyvan Razazi; Jean-Paul Mira; Laurent Argaud; Jean-Charles Chakarian; Jean-Damien Ricard; Xavier Wittebole; Stéphanie Chevalier; Alexandre Herbland; Muriel Fartoukh; Jean-Michel Constantin; Jean-Marie Tonnelier; Marc Pierrot; Armelle Mathonnet; Gaëtan Béduneau; Céline Delétage-Métreau; Jean-Christophe M Richard; Laurent Brochard; René Robert
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

Review 8.  European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

Authors:  J Chastre; F Blasi; R G Masterton; J Rello; A Torres; T Welte
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

9.  [Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy].

Authors:  K Dalhoff; M Abele-Horn; S Andreas; T Bauer; H von Baum; M Deja; S Ewig; P Gastmeier; S Gatermann; H Gerlach; B Grabein; G Höffken; W V Kern; E Kramme; C Lange; J Lorenz; K Mayer; I Nachtigall; M Pletz; G Rohde; S Rosseau; B Schaaf; R Schaumann; D Schreiter; H Schütte; H Seifert; H Sitter; C Spies; T Welte
Journal:  Pneumologie       Date:  2012-12-06

10.  Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.

Authors:  Mical Paul; Jihad Bishara; Dafna Yahav; Elad Goldberg; Ami Neuberger; Nesrin Ghanem-Zoubi; Yaakov Dickstein; William Nseir; Michael Dan; Leonard Leibovici
Journal:  BMJ       Date:  2015-05-14
View more
  5 in total

1.  Community-Acquired Pneumonia-an Underestimated Challenge.

Authors:  Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

2.  Comparative efficacy of Chinese herbal injections for treating severe pneumonia: A protocol for systematic review and Bayesian network meta-analysis of randomized controlled trials.

Authors:  Lu Xiao; Liqing Niu; Xuemin Zhang; Xuezheng Liu; Xinqiao Liu; Chongxiang Sun; Xiaokun Yang
Journal:  PLoS One       Date:  2022-05-23       Impact factor: 3.752

Review 3.  Comparative Efficacy of Chinese Herbal Injections for Treating Severe Pneumonia: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Liqing Niu; Lu Xiao; Xuemin Zhang; Xuezheng Liu; Xinqiao Liu; Xianglong Huang; Mingzhu Zhang
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

4.  Raman Spectroscopic Differentiation of Streptococcus pneumoniae From Other Streptococci Using Laboratory Strains and Clinical Isolates.

Authors:  Marcel Dahms; Simone Eiserloh; Jürgen Rödel; Oliwia Makarewicz; Thomas Bocklitz; Jürgen Popp; Ute Neugebauer
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

5.  Ventilator for the management of patients with severe pneumonia: A protocol of systematic review.

Authors:  Jian-Rong Sun; Huan-Huan Wang; Long-Ze Zong; Wei-Wei Yuan; Zhi-Yuan Bai
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.